Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hawthorn refers to the leaves, berries, flowers, and roots of plants in the Crataegus genus (including C. monogyna, C. oxyacantha, C. laevigata, C. pinnatifida, and C. mexicana) that are used medicinally. It contains flavonoids with antioxidant properties that appear to improve blood circulation and affect blood flow from the heart. Hawthorn has positive inotropic effects, causes peripheral vasodilation, increases myocardial perfusion, and may have antiarrhythmic activity by increasing the refractory period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hawthorn.